If upcoming news further validates HerVaxx and PD1Vaxx then we can relax some more knowing that these products will more than likely start producing income for us.
If HerVaxx has a shocker or statistically goes backwards from the interim data then it might send some ripples across the pond. Correct me if I am wrong, but HerVaxx is an open label study and LC knows which patient was in which line of treatment. She seemed pretty excited about getting these results finalized and out to the world.
PD1Vaxx is going 'Gang Busters' she said.
I'm not worried about lack of income from sales at this paradigm point in time.
Analysts Reports (Imugene), page-61
-
- There are more pages in this discussion • 278 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $379.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.2¢ | 5.0¢ | $1.098M | 21.50M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 97 | 7481668 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 1703097 | 4 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |